drugset / Trial / NCT06609005
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
Non-randomizedSequentialOpen-labelTreatment
Summary
This is a Phase 1 and Phase 2 study to evaluate the safety and antitumor activity of INV-9956 in adult patients with advanced metastatic Castration Resistant Prostate Cancer.
Timeline
- Start
- 2025-01-23
- Primary completion
- 2028-01-17
- Completion
- 2028-01-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INV-9956 | Unknown | — | — |